Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

This publication has 24 references indexed in Scilit:

• Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy
  Clinical Cancer Research, 2005
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  The Lancet, 2005
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy
  Cancer, 2004
• A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
  New England Journal of Medicine, 2002
• Gene expression profiling predicts clinical outcome of breast cancer
  Nature, 2002
• Polychemotherapy for early breast cancer: an overview of the randomised trials
  The Lancet, 1998
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
  Histopathology, 1991
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
  Science, 1987